Sponsor:
Epividian
Code:
NCT03813862
Conditions
Chronic Disease
HIV/AIDS
Liver Diseases
Inflammatory Bowel Diseases
Cardiovascular Diseases
Eligibility Criteria
Sex: All
Age: 0+
Healthy Volunteers: Accepted
Interventions
Non-interventional (observational only)
Brief summary:
Conditions
Chronic Disease
HIV/AIDS
Liver Diseases
Inflammatory Bowel Diseases
Cardiovascular Diseases
Study ID
NCT03813862
Start date
Dec 1, 2013
Status verified date
Feb, 2025
Completion date
Nov, 2035
Anticipated
Primary completion date
Nov, 2035
Anticipated
Eligibility Criteria
Sex: All
Age: 0+
Healthy Volunteers: Accepted
Enrollment
2000000 participants
Anticipated
Interventions
Non-interventional (observational only)
Primary outcome measure
Central contacts
Locations
Epividian
Recruiting
Durham, North Carolina, United States, 27703
Contacts
Sponsor
Epividian
Last update posted
Feb 25, 2025
Last verified
Feb, 2025
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Epividian on 2025-02-25.